Clinical Trial Update: Immune and Viral Outcomes of HIV-1 Therapy Interruption [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the immune and viral effects of interrupting HIV-1 therapy; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: The Wistar Institute | Conditions: HIV Infections | Phase 1 | Status: COMPLETED